MEGAN DANIELS: Open Payments
NPI 1053827469 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,778 in 140 payments from 17 companies in 2025. Trend: 2023 $584 · 2024 $2,073 · 2025 $2,778
Food & beverage: $2,778
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $555 |
| Janssen Biotech, Inc. | 25 | $542 |
| ABBVIE INC. | 42 | $468 |
| Madrigal Pharmaceuticals | 11 | $336 |
| Gilead Sciences, Inc. | 6 | $182 |
| QOL Medical, LLC | 7 | $122 |
| Pharmacosmos Therapeutics Inc. | 1 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| GENZYME CORPORATION | 4 | $85 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, EOHILIA, RINVOQ, DUPIXENT, LINZESS, Sucraid.
Industry payments across IN — which companies pay providers there.
